Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 5/20 | 0.44 |
| ▸ | CES1 | P23141 | 5/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1241955 | 0.85 | CES2 (0.44) | CES2CES1CA9CA3CA6 | |
| SCHEMBL13863241 | 0.70 | CA9 (0.48) | CES2CES1CA9CA3CA6 | |
| SCHEMBL1243166 | 0.68 | CES2 (0.39) | CES2CES1 | |
| SCHEMBL112046 | 0.63 | CES2 (0.61) | CES2CES1CA9CA14RAB9A | |
| SCHEMBL3180092 | 0.61 | CES2 (1.00) | CES2CES1CA9CA3CA6 | |
| SCHEMBL27673772 | 0.61 | CES2 (0.74) | CES2CES1CA9CA3CA6 | |
| SCHEMBL16962237 | 0.61 | NFE2L2 (0.54) | CES2CES1CA9CA3CA6 | |
| SCHEMBL10658758 | 0.61 | CES2 (0.48) | CES2CES1RAB9AMAPTLMNA | |
| SCHEMBL20139015 | 0.60 | CA3 (0.52) | CES2CES1CA9CA3CA6 | |
| SCHEMBL23931623 | 0.60 | CES2 (0.71) | CES2CES1CA9CA3CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170365855-A1 | LITHIUM BATTERY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-21 | — | — | US | claimed |
| US-20120183866-A1 | Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes | Brookhaven Science Associates ,LLC (US) | 2012-07-19 | — | — | US | claimed |
| WO-2011014451-A2 | FLUORINATED ARYLBORON OXALATE AS ANION RECEPTORS AND ADDITIVES FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-02-03 | — | — | WO | claimed |
| US-20170365855-A1 | LITHIUM BATTERY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-21 | — | — | US | disclosed |
| US-20120183866-A1 | Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes | Brookhaven Science Associates ,LLC (US) | 2012-07-19 | — | — | US | disclosed |
| WO-2011014451-A2 | FLUORINATED ARYLBORON OXALATE AS ANION RECEPTORS AND ADDITIVES FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120183866-A1 | Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes | SLCO2B1, SLCO1B1, SLCO4C1 | CES2 2634/4885CES1 3715/4885CA9 1068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.